U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807969) titled 'An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participan... Read More
U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807800) titled 'A Study of DES-1357 in People With Deficient Mismatch Repair (dMMR)/Microsatellite Instabil... Read More
U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807293) titled 'Radioguided Salvage Pelvic Node Dissection in Oligometastatic Prostate Cancer - SALVAGE' on... Read More
U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07806721) titled 'Family Grocery Study R01' on Sept. 01. Brief Summary: Obesity continues to be a major publ... Read More
U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807618) titled 'Effects of Small-Sided Games and Repeated Sprint Training in Young Soccer Players' on Sept.... Read More
U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807085) titled 'Apple Peptide Complex for Post-Surgical and Aesthetic Skin Recovery' on April 27. Brief Su... Read More
U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807358) titled 'INTUPROS 2-3: Improving First-Pass Intubation Success and Reducing Complications in ICU Pat... Read More
U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807410) titled 'Early Endotoxin Burden Reduction With oXiris in Septic Shock Patients Requiring CRRT' on Au... Read More
U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07806097) titled 'Self-Directed Upper Extremity Gaming in Inpatients With Stroke' on July 21. Brief Summary:... Read More
U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07808112) titled 'CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Re... Read More